Diagnostic accuracy and prognostic value of combined dipyridamole- exercise thallium imaging in hemodialysis patients

Kidney International

Volumn 54, Issue 1, 1998, Pages 255-262

  Dahan, Michel ^b   Viron, Béatrice M ^b   Faraggi, Marc ^b   Himbert, Dominique L ^b   Legallicier, Bruno J J ^b   Kolta, Amir M ^b   Pessione, Fabienne ^b   Le Guludec, Dominique ^b   Gourgon, R ^b   Mignon, Françoise E ^a  

^a BICHAT HOSPITAL   (France)

^b NONE

Author keywords

Chronic dialysis; Coronary artery disease; Diabetes; Myocardial infarction; Non invasive imaging; Renal mortality; Revascularization; Stress thallium imaging

Indexed keywords

DIPYRIDAMOLE; THALLIUM;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; EXERCISE; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

EID: 7144253138     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00988.x     Document Type: Article

References (41)

1. RAINE AEG, MARGREITER R, BRUNNER FP, EHRICH JHH, GEEELINGS W, LANDAIS P, LOIRAT C, MALLICK NP, SELWOOD NH, TUFVESON G, VALDERRABANO F: Report on the management of renal failure in Europe, XXII, 1991. Nephrol Dial Transplant 7(Suppl 2):7-35, 1992
2. ROSTAND SG, RUTSKY EA: Ischemic heart disease in chronic renal failure: Demography, epidemiology and pathogenesis, in Cardiaque Dysfunction in Chronic Uremia, edited by PARFREY PS, HARNETT JD, Boston, Kluwer Academic Publishers, 1992, pp 67-81
3. LEIER CV, GOUDOULAS H: Renal disorders and heart disease: Accelerated coronary atherosclerosis, in Braunwald Heart Disease (vol 2), Philadelphia/London/Toronto/Montréal/Sydney/Tokyo, WB Saunders Company, 1997, pp 1924-1927
4. TALIERCIA CP, VLIESTRA RE, FISHER LD, BURNETT JC: Risks for renal dysfunction with cardiac angiography. Ann Intern Med 104:501-550, 1986
5. ROIG E, BETRIU A, CASTANER A, MAGRINA J, SANZ G, NAVARRA-LOPEZ F: Disabling angina pectoris with normal coronary arteries in patients undergoing hemodialysis. Am J Med 71:437-444, 1981
6. RUTSKY EA, ROSTAND SG: The management of coronary artery disease in patients with end-stage renal disease, in Cardiac Dysfunction in Chronic Uremia, Boston/Basle, Kluwer Academic Publishers, 1992, pp 233-235
7. PHILIPSON JD, CARPENTER BJ, ITZKOFF J, HAKALA TR, ROSENTHAL JT, TAYLOR RJ, PUSCHETT JB: Evaluation of cardiovascular risk for renal transplantation in diabetic patients. Am J Med 81:630-634, 1986
8. MORROW CE, SCHWARTZ JS, SUTHERLAND DER, SIMMONS RL, FERGUSON RM, KJELLSTRAND CM, NAJARIAN JS: Predictive value of thallium stress testing or coronary and cardiovascular events in uremic diabetic patients before renal transplantation. Am J Surg 146:331-335, 1983
9. BOUDREAU RJ, STRONY JT, DU CRET RP, KUNI CC, WANG Y, WILSON RF, SCHWARTZ JS, CASTANEDA ZUNIGA WR: Perfusion thallium imaging of type I diabetes patients with end stage renal disease: Comparison of oral and intravenous dipyridamole administration. Cardiac Radiol 175:103-105, 1990
10. JOSEPHSON MA, BROWN BG, HECHT HS, HOPKINS J, PIERCE CD, PETERSEN RB: Non-invasive detection and localization of coronary stenoses in patients: comparison of resting dipyridamole and exercise thallium 201 myocardial perfusion imaging. Am Heart J 103:1008-1018, 1982
11. WIZEMANN V: Coronary artery disease in dialysis patients. Nephron 74:642-651, 1996
12. FOLEY RN, PARFREY PS, HARNETT JD, KENT GM, MARTIN CJ, MURRAY DC, GARRE PE: Clinical and echocadiographic disease in patients starting end stage renal disease therapy. Kidney Int 47:186-192, 1995
13. RITZ E, RAMBAUSEK M, MALL G, RUFFMAN K, SCHMIDLI M, HUTHER W: Cardiac hypertrophy in uremia, in Séminaires d'Uronéphrologie, edited by CHATELAIN C, JACOBS C, Paris, Masson, 1987, pp 195-205
14. DE PUEY EG, GUERTLER-KRAWCYNSKA E, PERKINS JV, ROBBINS WL, WHELCHEL JD, CLEMENTS SD: Alterations in myocardial thallium 201 distribution in patients undergoing single-photon emission computed tomography. Am J Cardiol 62:234-238, 1988
15. HOUGHTON JL, FRANK MJ, CARR AA, VON DOHLEN TW, PRISANT M: Relations among impaired coronary flow reserve, left ventricular hypertrophy and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease. J Am Coll Cardiol 15:43-51, 1990
16. SCHULMAN DS, FRANCIS CK, BLACK HR, WACKERS FJ: Thallium-201 stress imaging in hypertensive patients. Hypertension 10:16-21, 1987
17. DAOU D, LE GULUDEC D, FARAGGI M, FOULT JM, LEBTAHI R, COHEN SOLAL A, ASSAYAG P, STEG G: Non-limited exercise test combined with high-dose dipyridamole for thallium-201 myocardial single-photon emission computed tomography in coronary artery disease. Am J Cardiol 76:753-758, 1995
18. VERZIJLBERGEN F, VERMEERSCH PHMMJ, LAARMAN GJ, ASCOOP CAPL: Inadequate exercise leads to suboptimal imaging. Thallium-201 myocardial perfusion imaging after dipyridamole combined with low-level exercise unmasks ischemia in symptomatic patients with non-diagnostic thallium-201 scans who exercise submaximally. J Nucl Med 32:2071-2078, 1991
19. HURWITZ GA, POWE JE, DRIEDGER AA, FINNIE KJC, LAURIN NR, MACDONALD AC: Dipyridamole combined with symptom-limited exercise for myocardial perfusion scintigraphy: Image characteristics and clinical role. Eur J Nucl Med 17:61-68, 1990
20. BROWN KA: Prognostic value of myocardial perfusion imaging: State of the art and new developments. J Nucl Cardiol 3:516-537, 1996
21. GIBSON RS, WATSON DD, CRADDOCK GB, CRAMPTON RS, KAISER DL, DENNY MJ, BELLER GA: Prediction of cardiac events after uncomplicated myocardial infarction: A prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography. Circulation 68:321-336, 1983
22. MACHECOURT J, LONGÈRE P, FAGRET D, VANZETTO G, WOLF J, POLIDORI C, COMET M, DENIS B: Prognostic value of thallium-201 single-photon emission computed tomographic myocardial perfusion imaging according to extent of myocardial defect. J Am Coll Cardiol 23:1096-1106, 1994
23. BROWN KA, RIMMER J, HAISCH C: Non-invasive cardiac risk stratification of diabetic and non-diabetic uremic renal allograft candidates using dipyridamole Thallium-201 imaging and radionuclide ventriculography. Am J Cardiol 64:1017-1021, 1989
24. CAMP AD, GARVIN PJ, HOFF J MARSH J, BYERS SL, CHAITMAN BR: Prognostic value of intravenous dipyridamole thallium imaging in patients with diabetes mellitus considered for renal transplantation. Am J Cardiol 65:1459-1463, 1990
25. BROWN JH, VITES NP, TESTA HJ, PRESCOTT MC, HUNT LP, GOKAL R, MALLICK NP: Value of thallium myocardial imaging in the prediction of future cardiovascular events in patients with end-stage renal failure. Nephrol Dial Transplant 8:433-437, 1993
26. BARON JF, MUNDLER O, BERTRAND M, VICAUT E, BARRÉ E, GODET G, SAMAMA CM, CORIAT P, KIEFFER E, VIARS P: Dipyridamole thallium scintigraphy and gated radionuclide angiography to assess cardiac risk before abdominal aortic surgery. N Engl J Med 330:663-669, 1994
27. MANGANO DT, LONDON MJ, TUBAU JF, BROWNER WS, HOLLENBERG M, KRUPSKI W, LAYUG EL, MASSIE B: Dipyridamole thallium-201 scintigraphy as a preoperative screening test. Circulation 84:493-502, 1991
28. DEVEREUX RB, ALONSO DR, LUTAS EM, GOTTLIEB GJ, CAMPO E, SACHS I, REICHEK N: Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 57:450-458, 1986
29. AMERICAN SOCIETY OF ECHOCARDIOGRAPHY COMMITTEE ON STANDARDS, SUBCOMMITTEE ON QUANTITATION OF TWO-DIMENSIONAL ECHOCARDIOGRAMS: Recommendation for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 2:361-367, 1989
30. KIAT H, VAN TRAIN KF, FRIEDMAN JD, GERMANO G, SILAGAN G, PING WANG F, MADDAHI J, PRIGENT F, BERMAN DS: Quantitative stress-redistribution thallium-201 SPECT using prone imaging: Methodologic development and validation. J Nucl Medicine 33:1509-1515, 1992
31. Cox DR, OAKES D: Analysis of Survival Data, London, Chapman and Hall, 1984
32. BLOCH DA: Comparing two tests against the same gold standard in the same sample. Biometrics 53:73-85, 1997
33. DE LEMOS JA, HILLIS LD: Diagnosis and management of coronary artery disease in patients with end stage renal disease on hemodialysis. J Am Soc Nephrol 7:2044-2054, 1996
34. MURPHY SW, PARFREY PS: Screening for cardiovascular disease in dialysis patients. Curr Opin Nephrol Hypertens 5:532-540, 1996
35. WIZEMANN V, KAUFMANN J, KRAMER W: Effect of erythropoietin on ischemia tolerance in anemic hemodialysis patients with confirmed coronary artery disease. Nephron 62:161-165, 1992
36. KRAMER W, WIZEMANN V, LÄMMLEIN G: Cardiac dysfunction in patients on maintenance hemodialysis. Contributions in Nephrology (vol 52), Basel, Karger, 1986, pp 110-124
37. CECIL MP, PILCHER WC, EISNER RL, CHU TH, MERLINO JD, PATTERSON RE: Absence of defects in SPECT thallium-201 myocardial images in patients with systemic hypertension and left ventricular hypertrophy. Am J Cardiol 74:43-46, 1994
38. MARWICK TH, COOK SA, LAFONT A, UNDERWOOD DA, SALCEDO EE: Influence of left ventricular mass on the diagnostic accuracy of myocardial perfusion imaging using positron emission tomography with dipyridamole stress. J Nucl Med 32:2221-2226, 1991
39. LEPPO JA: Myocardial uptake of thallium and rubidium during alterations in perfusion and oxygenation in isolated rabbit hearts. J Nucl Med 28:878-885, 1987
40. GIBSON RS, BELLER GA, GHEORGHIADE M, NYGAARD TW, WAATSON DD, HUEY EL, SAYRE SL, KAISER DL: The prevalence and clinical significance of residual myocardial ischemia 2 weeks after uncomplicated non-Q-wave myocardial infaretion: a prospective natural history study. Circulation 73:1186-1198, 1986
41. MANSKE C, WANG Y, WILSON RF, RECTOR T, WHITE CW: Coronary revascularization in insulin-dependent diabetic patients with chronic renal failure. Lancet 340:998-1002, 1992